| 7480- | Hup, | Pharmacokinetics of huperzine A following oral administration to human volunteers |
| - | Trial, | AD, | NA |
| 7602- | I3C, | Dose-ranging study of indole-3-carbinol for breast cancer prevention |
| - | Trial, | BC, | NA |
| 7611- | I3C, | Long-term responses of women to indole-3-carbinol or a high fiber diet |
| - | Trial, | Nor, | NA |
| 7580- | I3C, | Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3'-diindolylmethane |
| - | Trial, | NA, | NA |
| 7581- | I3C, | A phase I study of indole-3-carbinol in women: tolerability and effects |
| - | Trial, | Nor, | NA |
| 7578- | IMA, | Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia |
| - | Trial, | CML, | NA |
| 7579- | IMA, | One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial |
| - | Trial, | GC, | NA |
| 7616- | Ins, | A phase I study of myo-inositol for lung cancer chemoprevention |
| - | Trial, | Nor, | NA |
| 7634- | Ins, | Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors |
| - | Trial, | Nor, | NA |
| 7643- | Ins, | IP6, | Efficacy of IP6 + inositol in the treatment of breast cancer patients receiving chemotherapy: prospective, randomized, pilot clinical stud |
| - | Trial, | BC, | NA |
| 7633- | Ins, | Myo-inositol in a new pharmaceutical form: a step forward to a broader clinical use |
| - | Trial, | Nor, | NA |
| 7673- | iod, | Chemo, | Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized Pilot Study |
| - | Trial, | BC, | NA |
| 7672- | iod, | Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized Pilot Study |
| - | Trial, | BC, | NA |
| 7684- | iod, | Molecular iodine impairs chemotherapy resistance and adverse effects in breast cancer treatments |
| - | Trial, | BC, | NA |
| - | Trial, | Nor, | NA |
| 7662- | IP, | Digestive tolerance of inulin-type fructans: a double-blind, placebo-controlled, cross-over, dose-ranging, randomized study in healthy volunteers |
| - | Trial, | Nor, | NA |
| 7664- | IP, | GCL2505, | Administration of bifidobacteria and dietary fiber improves cognitive function by increasing short-chain fatty acid-producing bacteria and reducing inflammation |
| - | Trial, | AD, | NA |
| 7665- | IP, | A Prebiotic-Supplemented Formula Improves Gut Microbiota and Intestinal Inflammatory Microenvironment in Patients with Colorectal Adenoma: A Double-Blind, Placebo-Controlled Trial |
| - | Trial, | Nor, | NA |
| 7666- | IP, | Short-chain fatty acid kinetics and concentrations are higher after inulin supplementation in young and older adults: a randomized trial |
| - | Trial, | Nor, | NA |
| 7668- | IP, | A phase 2 randomized, placebo-controlled trial of inulin for the prevention of gut pathogen colonization and infection among patients admitted to the intensive care unit for sepsis |
| - | Trial, | Sepsis, | NA |
| 7640- | IP6, | Ins, | Effects of Inositol Hexaphosphate and Myo-Inositol Administration in Breast Cancer Patients during Adjuvant Chemotherapy |
| - | Trial, | BC, | NA |
| 7741- | isoFl, | Lyco, | SIL, | Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement |
| - | Trial, | Pca, | NA |
| 7740- | isoFl, | Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial |
| - | Trial, | Pca, | NA |
| 7738- | isoFl, | Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced pro-inflammatory cytokines and immune suppressive cells |
| - | Trial, | Pca, | NA |
| 7731- | isoFl, | Long-term soy isoflavone supplementation and cognition in women: a randomized, controlled trial |
| - | Trial, | AD, | NA |
| 7850- | ISQ, | Effect of quercetin glycosides on cognitive functions and cerebral blood flow: a randomized, double-blind, and placebo-controlled study |
| - | Trial, | Nor, | NA |
| 7996- | itraC, | Itraconazole in the Treatment of Aberrantly Active Hedgehog and/or PI3K Recurrent Ovarian Cancer |
| - | Trial, | Ovarian, | NA |
| 7991- | itraC, | A Phase II Trial of Perioperative Oral Itraconazole for the Management of Low-Risk Basal Cell Carcinoma |
| - | Trial, | BCC, | NA |
| 7990- | itraC, | A Novel Approach to Reducing Chemoresistance in Advanced Ovarian Cancer: The Effect of Itraconazole-A Single-Institution Randomized Placebo-Controlled Trial |
| - | Trial, | Ovarian, | NA |
| 7989- | itraC, | Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung Cancer |
| - | Trial, | NSCLC, | NA |
| 7988- | itraC, | Itraconazole as a Noncastrating Treatment for Biochemically Recurrent Prostate Cancer: A Phase 2 Study |
| - | Trial, | Pca, | NA |
| 7987- | itraC, | Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer |
| - | Trial, | Pca, | NA |
| 7986- | itraC, | Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma |
| - | Trial, | BCC, | NA |
| 8018- | itraC, | Chemo, | Impact of combination chemotherapy with itraconazole on survival of patients with refractory ovarian cancer |
| - | Trial, | Ovarian, | NA |
| 8058- | KAE, | A randomized, placebo‐controlled trial evaluating the safety of excessive administration of kaempferol aglycone |
| - | Trial, | Nor, | NA |
| - | Trial, | Nor, | NA |
| 8110- | L-Orn, | L-ornithine supplementation attenuates physical fatigue in healthy volunteers by modulating lipid and amino acid metabolism |
| - | Trial, | Nor, | NA |
| 8119- | LA, | Perioperative synbiotics administration decreases postoperative infections in patients with colorectal cancer: a randomized, double-blind clinical trial |
| - | Trial, | CRC, | NA |
| - | Trial, | CRC, | NA |
| - | Trial, | CRC, | NA |
| 1272- | LA, | Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults |
| - | Trial, | Nor, | NA |
| 8158- | lamb, | Effect of Pinus koraiensis leaf extract on fatigue reduction and exercise performance: study protocol for a randomized, double-blind, placebo-controlled clinical trial |
| - | Trial, | Nor, | NA |
| 8172- | Lap, | Administration of Lapatinib with Food Increases Its Plasma Concentration in Chinese Patients with Metastatic Breast Cancer: A Prospective Phase II Study |
| - | Trial, | BC, | NA |
| 8171- | Lap, | Effects of food on the relative bioavailability of lapatinib in cancer patients |
| - | Trial, | Var, | NA |
| - | Trial, | BC, | NA |
| 8123- | LF, | Effect of orally administered bovine lactoferrin on the growth of adenomatous colorectal polyps in a randomized, placebo-controlled clinical trial |
| - | Trial, | CRC, | NA |
| 8124- | LF, | Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine |
| - | Trial, | CRC, | NA |
| 8125- | LF, | Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial) |
| - | Trial, | NSCLC, | NA |
| 8127- | LF, | Phase I trial of oral talactoferrin alfa in refractory solid tumors |
| - | Trial, | Var, | NA |
| 8128- | LF, | Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma |
| - | Trial, | RCC, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid